Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
New genetic test for Burmese cat mutation
c/o Photocat
Cat breed set to benefit from new test

A new genetic test has been developed for Burmese hypokalaemia, an inherited muscle weakness in Burmese cats, following the identification of the genetic mutation responsible by a research team which included academics from the University of Bristol.

An autosomal recessive disease, Burmese hypokalaemia is also known as Familial Episodic Hypokalaemic Polymyopathy. It can affect the whole animal or may be localised to the neck or limb muscles, and can result in problems walking or holding the head up correctly.

The new genetic test allows breeders, owners and vets to test for the disease. It is hoped that by genetic testing and selective breeding, the test could be used to eradicate the disease in the Burmese breed.

Dr Chris Helps, Head of Molecular Diagnostic Unit at LVS, University of Bristol, commented: "It is possible to continue to use carrier cats in breeding programmes to retain important breeding lines and to avoid reducing the size of the Burmese gene pool. As long as carrier cats are mated to normal cats, no affected kittens will be produced. This mating is likely to produce kittens that are carriers, which can be identified by genetic testing and, if necessary, future matings arranged with normal cats."

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.